COMMUNIQUÉS West-GlobeNewswire

Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
17/03/2026
On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan- [...]
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
17/03/2026
WESTBROOK, Maine, March 17, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to release financial [...]
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
17/03/2026
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the United States SALT LAKE CITY, March 17, 2026 (GLOBE [...]
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates
17/03/2026
Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On track to initiate a Phase [...]
HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook
17/03/2026
Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion. Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year. Net income per diluted share rose to $ [...]
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
17/03/2026
MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and [...]
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
17/03/2026
KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the third [...]
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
17/03/2026
Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals,” the “Company,” or “MangoRx”), a company focused on developing, marketing, and selling health and wellness products [...]
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
17/03/2026
Public release of Virbac Consolidated Accounts at 31 December 2025. The Group released its 2025 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under “Investors”, “ [...]
Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025
17/03/2026
Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2025 sur le site internet du Groupe, à l’adresse [...]
UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference
17/03/2026
EAGLE, Idaho, March 17, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Compass Health Invites Community to “Camp Out” for Youth Behavioral Health
17/03/2026
Annual fundraiser supports programs for children, youth, and families across Northwest Washington EVERETT, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- For fifteen years, Compass Health has hosted therapeutic camps that [...]
Virbac: 2025 annual results
17/03/2026
A robust adjusted EBIT margin² of 16.3% at CERS, driven by solid organic revenue growth of 7.9% Solid 2025 dynamic with annual revenue up +7.9% at CERS; with strong momentum in key categories and countries. Volume/mix [...]
Virbac : résultats annuels 2025
17/03/2026
Une marge opérationnelle 2 robuste de 16,3 %, portée par une solide croissance organique du chiffre d'affaires de 7,9 %. Dynamique 2025 solide avec un chiffre d'affaires annuel en hausse de +7,9 % à périmètre et taux de [...]
SK pharmteco annonce le succès de l’inspection de son site de fabrication de petites molécules par la FDA, à La Porte, au Texas
17/03/2026
RANCHO CORDOVA, Californie, 17 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui l’issue favorable de l’inspection réglementaire de son site de petites molécules en Amérique du Nord, situé à La Porte, au [...]
Naturonel Launches Made-in-USA Herbal Supplements to Support Metabolic Wellness
17/03/2026
New line of plant-based dietary supplements tested for purity and potency now available to consumers nationwide. Naturonel Image PRINCETON, N.J., March 17, 2026 (GLOBE NEWSWIRE) -- Naturonel, a wellness brand focused on [...]
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
17/03/2026
Jails outpace prisons in offering MOUD, but regional disparities and limited treatment access persist across the U.S. Qualitative feedback points to need for greater reentry support, housing, care coordination, and [...]
Personalized Keto Made Easy: How Ketoway Supports Consistent Results and Healthy Habits
17/03/2026
Ketoway Helps Users Achieve Lasting Keto Success with Personalized Meal Plans, Guided Workouts, and Transparent Customer Support NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Ketoway is a personalized keto-diet app [...]
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
17/03/2026
Vancouver, Canada, March 17, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non- [...]

Pages